These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400 [TBL] [Abstract][Full Text] [Related]
26. Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome. Milano MT; Chmura SJ; Garofalo MC; Rash C; Roeske JC; Connell PP; Kwon OH; Jani AB; Heimann R Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):445-53. PubMed ID: 15145161 [TBL] [Abstract][Full Text] [Related]
27. Effect of radiation techniques in treatment of oropharynx cancer. Rusthoven KE; Raben D; Ballonoff A; Kane M; Song JI; Chen C Laryngoscope; 2008 Apr; 118(4):635-9. PubMed ID: 18176348 [TBL] [Abstract][Full Text] [Related]
28. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer. Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807 [TBL] [Abstract][Full Text] [Related]
29. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy. Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501 [TBL] [Abstract][Full Text] [Related]
30. Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy. Wong WW; Vora SA; Schild SE; Ezzell GA; Andrews PE; Ferrigni RG; Swanson SK Cancer; 2009 Dec; 115(23):5596-606. PubMed ID: 19670452 [TBL] [Abstract][Full Text] [Related]
31. Intensity modulated radiotherapy (IMRT) in patients with carcinomas of the paranasal sinuses: clinical benefit for complex shaped target volumes. Combs SE; Konkel S; Schulz-Ertner D; Münter MW; Debus J; Huber PE; Thilmann C Radiat Oncol; 2006 Jul; 1():23. PubMed ID: 16859556 [TBL] [Abstract][Full Text] [Related]
32. Lymph node metastasis in sinonasal squamous cell carcinoma treated with IMRT/3D-CRT. Guan X; Wang X; Liu Y; Hu C; Zhu G Oral Oncol; 2013 Jan; 49(1):60-5. PubMed ID: 22884302 [TBL] [Abstract][Full Text] [Related]
33. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer. Al-Mamgani A; Heemsbergen WD; Peeters ST; Lebesque JV Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):685-91. PubMed ID: 18718725 [TBL] [Abstract][Full Text] [Related]
34. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy. Schoenfeld JD; Sher DJ; Norris CM; Haddad RI; Posner MR; Balboni TA; Tishler RB Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):308-14. PubMed ID: 21075557 [TBL] [Abstract][Full Text] [Related]
35. Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer. Madani I; Vakaet L; Bonte K; Boterberg T; De Neve W Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1158-66. PubMed ID: 18258383 [TBL] [Abstract][Full Text] [Related]
36. Long-term outcomes of IMRT for breast cancer: a single-institution cohort analysis. McDonald MW; Godette KD; Butker EK; Davis LW; Johnstone PA Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1031-40. PubMed ID: 18440727 [TBL] [Abstract][Full Text] [Related]
37. The impact of treatment modality and radiation technique on outcomes and toxicity of patients with locally advanced oropharyngeal cancer. Al-Mamgani A; van Rooij P; Verduijn GM; Mehilal R; Kerrebijn JD; Levendag PC Laryngoscope; 2013 Feb; 123(2):386-93. PubMed ID: 23404489 [TBL] [Abstract][Full Text] [Related]
38. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Lee NY; de Arruda FF; Puri DR; Wolden SL; Narayana A; Mechalakos J; Venkatraman ES; Kraus D; Shaha A; Shah JP; Pfister DG; Zelefsky MJ Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):966-74. PubMed ID: 17145527 [TBL] [Abstract][Full Text] [Related]
39. Malignant tumors of the nasal cavity and paranasal sinuses: long-term outcome and morbidity with emphasis on hypothalamic-pituitary deficiency. Snyers A; Janssens GO; Twickler MB; Hermus AR; Takes RP; Kappelle AC; Merkx MA; Dirix P; Kaanders JH Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1343-51. PubMed ID: 18963535 [TBL] [Abstract][Full Text] [Related]
40. Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Harsolia A; Kestin L; Grills I; Wallace M; Jolly S; Jones C; Lala M; Martinez A; Schell S; Vicini FA Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1375-80. PubMed ID: 17544598 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]